140 related articles for article (PubMed ID: 23338846)
1. Comparison of microscopic (pT3a) and gross extravesical extension (pT3b) in pathological staging of bladder cancer: analysis of patient outcomes.
Dincel C; Kara C; Balci U; Ozer K; Ozbir S; Sefik E; Gorgel SN; Girgin C
Int Urol Nephrol; 2013 Apr; 45(2):387-93. PubMed ID: 23338846
[TBL] [Abstract][Full Text] [Related]
2. Microscopic invasion of perivesical fat by urothelial carcinoma: implications for prognosis and pathology practice.
Scosyrev E; Yao J; Messing E
Urology; 2010 Oct; 76(4):908-13; discussion 914. PubMed ID: 20709375
[TBL] [Abstract][Full Text] [Related]
3. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
[TBL] [Abstract][Full Text] [Related]
4. pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder.
Tilki D; Svatek RS; Karakiewicz PI; Novara G; Seitz M; Sonpavde G; Gupta A; Kassouf W; Fradet Y; Ficarra V; Skinner E; Lotan Y; Sagalowsky AI; Stief CG; Reich O; Shariat SF
J Urol; 2010 Aug; 184(2):470-4. PubMed ID: 20620401
[TBL] [Abstract][Full Text] [Related]
5. Natural history of surgically treated bladder carcinoma with extravesical tumor extension.
Quek ML; Stein JP; Clark PE; Daneshmand S; Miranda G; Cai J; Groshen S; Lieskovsky G; Quinn DI; Raghavan D; Skinner DG
Cancer; 2003 Sep; 98(5):955-61. PubMed ID: 12942562
[TBL] [Abstract][Full Text] [Related]
6. Utility of pT3 substaging in lymph node-negative urothelial carcinoma of the bladder: do pathologic parameters add to prognostic sub-stratification?
Maas M; Mischinger J; Compérat E; Scharpf M; Fend F; Todenhöfer T; Stenzl A; Gakis G; Rausch S
World J Urol; 2021 Nov; 39(11):4021-4027. PubMed ID: 33881556
[TBL] [Abstract][Full Text] [Related]
7. Microscopic and gross extravesical extension in pathological staging of bladder cancer.
Quek ML; Stein JP; Clark PE; Daneshmand S; Miranda G; Cai J; Groshen S; Cote RJ; Lieskovsky G; Quinn DI; Skinner DG
J Urol; 2004 Feb; 171(2 Pt 1):640-5. PubMed ID: 14713777
[TBL] [Abstract][Full Text] [Related]
8. Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.
Bastian PJ; Hutterer GC; Shariat SF; Rogers CG; Palapattu GS; Lotan Y; Vazina A; Amiel GE; Gupta A; Sagalowsky AI; Lerner SP; Schoenberg MP; Karakiewicz PI;
BJU Int; 2008 Feb; 101(4):450-4. PubMed ID: 17850359
[TBL] [Abstract][Full Text] [Related]
9. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
10. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of 34 cases of infiltrating carcinoma of the bladder treated exclusively with partial cystectomy (part 1)].
Escudero Barrilero A; Fernández Fernández E; Jiménez Cidre M; Maganto Pavón E; Mayayo Dehesa T; Rodríguez Rodríguez R; Galvis San Juan F; Burgos Revilla FJ
Arch Esp Urol; 1996 May; 49(4):349-64. PubMed ID: 8754191
[TBL] [Abstract][Full Text] [Related]
12. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA
J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101
[TBL] [Abstract][Full Text] [Related]
13. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
Frazier HA; Robertson JE; Dodge RK; Paulson DF
Cancer; 1993 Jun; 71(12):3993-4001. PubMed ID: 8508365
[TBL] [Abstract][Full Text] [Related]
14. Does the gross prosector impact pT3 subclassification or lymph node counts in bladder cancer?
Tretter EM; Ebel JJ; Pohar KS; Zynger DL
Hum Pathol; 2017 Mar; 61():190-198. PubMed ID: 27993579
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology Review.
Seisen T; Mari A; Campi R; Peyronnet B; Bensalah K; Rioux-Leclercq N; Pfister C; Gobet F; De La Taille A; Allory Y; Xylinas E; Neuzillet Y; Radulescu C; Descotes JL; Saada-Sebag G; Irani J; Delpech-Debiais C; Bigot P; Eymerit C; Crouzet S; Mege-Lechevallier F; Ruffion A; Decaussin-Petrucci M; Droupy S; Roger P; Durand X; Camparo P; Cussenot O; Compérat E; Rouprêt M
Eur Urol Focus; 2021 Sep; 7(5):1075-1083. PubMed ID: 33463527
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
[TBL] [Abstract][Full Text] [Related]
17. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
Stein JP; Cai J; Groshen S; Skinner DG
J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
[TBL] [Abstract][Full Text] [Related]
20. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
